Biblio

Found 5 results

Filters: Keyword is Cognitive Dysfunction [Clear All Filters]

2021

Ren B, Wang L, Shi L, Jin X, Liu Y, Liu RHai, Yin F, Cadenas E, Dai X, Liu Z et al.. 2021. Methionine restriction alleviates age-associated cognitive decline via fibroblast growth factor 21.. Redox Biol. 41:101940.

2020

Liu Z, Dai X, Zhang H, Shi R, Hui Y, Jin X, Zhang W, Wang L, Wang Q, Wang D et al.. 2020. Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment.. Nat Commun. 11(1):855.

Wang Y, Hernandez G, Mack WJ, Schneider LS, Yin F, Brinton RD. 2020. Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy.. Menopause. 27(1):57-65.

2019

Hay M, Polt R, Heien ML, Vanderah TW, Largent-Milnes TM, Rodgers K, Falk T, Bartlett MJ, Doyle KP, Konhilas JP. 2019. A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction.. J Pharmacol Exp Ther. 369(1):9-25.

2016

Rettberg JR, Dang H, Hodis HN, Henderson VW, St John JA, Mack WJ, Brinton RDiaz. 2016. Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype.. Neurobiol Aging. 40:155-63.